Cerity Partners’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
Cerity Partners's GDRX Position: Q1 2026 in Review
Cerity Partners increased its GoodRx Holdings (GDRX) stake by 41% in Q1 2026, buying an estimated $37K and bringing the position to 53,926 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3019.
Cerity Partners first reported a position in GDRX in Q3 2021 and has held it in 5 quarters since. The position peaked at $357K in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- Cerity Partners held 53,926 shares of GoodRx Holdings worth $106K as of Q1 2026.
- Cerity Partners bought 15,759 GoodRx Holdings shares in Q1 2026, an estimated $37K.
- GoodRx Holdings made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #3019 holding.
- Cerity Partners first reported a position in GoodRx Holdings in Q3 2021 and has held it in 5 quarters since.
- Cerity Partners's GoodRx Holdings position peaked at $357K in Q3 2021.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.